Skip to main content
BrainCited

Beschreibung

Main pathways for nanoparticle transport across the blood-brain barrier are illustrated, including adsorptive-mediated endocytosis for cationic nanoparticles and receptor-mediated transcytosis for transferrin-conjugated systems.

Figure 11

Diagram

Source Paper

Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology.

International journal of molecular sciences (2020)

PMID: 33375513

DOI: 10.3390/ijms22010196

Cite This Figure

![Figure 11: Main pathways for nanoparticle transport across the blood-brain barrier are illustrated, including adsorptive-mediated endocytosis for cationic nanoparticles and receptor-mediated transcytosis for transferrin-conjugated systems.]()

> Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." *International journal of molecular sciences*, 2020. PMID: [33375513](https://pubmed.ncbi.nlm.nih.gov/33375513/)
<figure>
  <img src="" alt="Main pathways for nanoparticle transport across the blood-brain barrier are illustrated, including adsorptive-mediated endocytosis for cationic nanoparticles and receptor-mediated transcytosis for transferrin-conjugated systems." />
  <figcaption>Figure 11. Main pathways for nanoparticle transport across the blood-brain barrier are illustrated, including adsorptive-mediated endocytosis for cationic nanoparticles and receptor-mediated transcytosis for transferrin-conjugated systems.<br>  Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." <em>International journal of molecular sciences</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33375513/">33375513</a></figcaption>
</figure>